Probiotics for Preterm Infants

Launched by ANKARA CITY HOSPITAL BILKENT · Mar 13, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the use of probiotics, which are beneficial bacteria, for preterm infants who are stable and have reached full feeding after being on a breathing machine. The trial aims to understand how these probiotics might help improve feeding outcomes in infants born before 32 weeks of pregnancy and who weigh less than 1500 grams at birth. While there are some concerns about starting probiotics early due to safety worries, previous studies have shown many positive effects.

To participate in this trial, infants must be less than 32 weeks old and weigh under 1500 grams at birth. However, infants with certain conditions, like congenital anomalies or those still receiving nutrients through an IV, will not be eligible. Although the trial is not yet recruiting participants, families can expect to receive more information about how probiotics could benefit their babies once it begins. This research could help improve the care and feeding of preterm infants in the future.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: \<32 weeks, \<1500 g birthweight -
• • Exclusion Criteria: Congential anomalies, still parenteral feeding, BW\<800 gr and \<23 weeks of GA
• • -